Malignant choroid melanoma
MONDO:0003878A uveal melanoma that arises from the choroid. It is the most common primary malignant intraocular tumor. It usually affects Caucasians of northern European descent. It usually remains asymptomatic for a long period. When signs and symptoms occur, they include blurred vision, visual field loss, floaters, and ocular pain. Tumor size is the most important factor that relates to prognosis.
Also known as: choroid malignant melanoma, choroid melanoma, choroidal melanoma, malignant melanoma of choroid, malignant melanoma of the choroid, melanoma (disease) of optic choroid, melanoma of choroid, melanoma of the choroid
2851 clinical trials for this condition and its sub-types, 10 tagged with Malignant choroid melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Malignant choroid melanoma
-
Choroid epithelioid cell melanoma 0 trials
-
Choroid mixed cell melanoma 0 trials
-
Choroid necrotic melanoma 0 trials
-
Choroid spindle cell melanoma 0 trials
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control Stopped earlyThis study tested two different proton therapy schedules for people with large choroidal melanomas (eye cancer) that would normally require removal of the eye. The goal was to see if a gentler radiation schedule could control the tumor and avoid severe side effects, allowing pati…
Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC